Login / Signup

Surgical management of liver tumors.

Kimberly J RiehleSanjeev A VasudevanAlexander BondocAlex G CuencaHanna GarnierZachary J KastenbergJonathan RoachChristopher B WeldonJonathan KarpelowskyTomoro HishikiGregory Tiao
Published in: Pediatric blood & cancer (2024)
Two percent of pediatric malignancies arise primarily in the liver; roughly 60% of these cancers are hepatoblastoma (HB). Despite the rarity of these cases, international collaborative efforts have led to the consistent histological classification and staging systems, which facilitate ongoing clinical trials. Other primary liver malignancies seen in children include hepatocellular carcinoma (HCC) with or without underlying liver disease, fibrolamellar carcinoma (FLC), undifferentiated embryonal sarcoma of the liver (UESL), and hepatocellular neoplasm not otherwise specified (HCN-NOS). This review describes principles of surgical management of malignant pediatric primary liver tumors, within the context of comprehensive multidisciplinary care.
Keyphrases
  • clinical trial
  • quality improvement
  • healthcare
  • palliative care
  • randomized controlled trial
  • machine learning
  • lymph node
  • pain management
  • open label
  • high grade
  • phase iii